Electromed (NYSE:ELMD) Earns Strong-Buy Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Electromed (NYSE:ELMDGet Rating) in a research note published on Monday. The brokerage issued a strong-buy rating on the stock.

Other analysts also recently issued research reports about the stock. Lake Street Capital assumed coverage on shares of Electromed in a research report on Friday, August 5th. They set a buy rating and a $20.00 price target for the company. EF Hutton Acquisition Co. I assumed coverage on shares of Electromed in a research report on Tuesday, September 6th. They set a buy rating and a $13.50 price target for the company.

Electromed Stock Down 0.9 %

Shares of NYSE:ELMD opened at $10.00 on Monday. Electromed has a 52-week low of $8.75 and a 52-week high of $13.46. The company has a 50 day moving average of $10.40 and a two-hundred day moving average of $10.36. The company has a market capitalization of $84.90 million, a price-to-earnings ratio of 45.46 and a beta of 0.49.

Electromed (NYSE:ELMDGet Rating) last issued its quarterly earnings data on Tuesday, August 23rd. The company reported $0.04 earnings per share (EPS) for the quarter. Electromed had a net margin of 4.60% and a return on equity of 5.73%. The company had revenue of $11.27 million during the quarter.

About Electromed

(Get Rating)

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.

Read More

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.